Results of an RCT showed that CBD 50 mg was not superior to placebo for reducing pain intensity among patients with fibromyalgia.

A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol (CBD)-like medicines ...

Though there is limited research on CBD, some small studies have found that it can help with anxiety, addiction, and epilepsy ...

Neuroinflammation damages neurons and can contribute to diseases like Alzheimer's. Cannabidiol (CBD) has anti-inflammatory ...

Cannabidiol may halve the severity of chronic anxiety symptoms and impairment in young people, an Orygen pilot study has shown Cannabidiol may be effective in halving the severity of symptoms and ...

Cannabidiol (Epidiolex) may alter blood levels of several commonly used antiepileptic drugs in adults and children, according to an open-label study published in Epilepsia. Cannabidiol showed ...

Escambia County received a development proposal to create a smoke shop that will sell cannabidiol (CBD) and hemp-based ...

CBD is everywhere, just Google it. Cannabidiol, the popular hemp plant derivative marketed as a cure-all for just about any condition, has only been approved by federal regulators to treat some rare ...

In Toronto, Charlotte's Web's shares jumped 78% to C$0.24, widening the advance in 2025 to 92%. Tilray Brands was 39% higher at C$2.24, Aurora Cannabis was ahead 30% at C$8.81, Curaleaf climbed 23% to ...

New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabidiol Global Market Report 2023" - https://www.reportlinker ...

The Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The ...